Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison.

European neurology2002Diener HC, Jansen JP, Reches A, et al.

Study designRandomized controlled trial

SubjectHuman

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

AdolescentAdultAgedCaffeineDose-Response Relationship, DrugDouble-Blind MethodDrug CombinationsErgotamineFemaleHumansIndolesMaleMiddle AgedMigraine DisordersPyrrolidinesSerotonin Receptor AgonistsTreatment OutcomeTryptamines

DOI 10.1159/000047960

PMID 11844898

View source →